<DOC>
	<DOCNO>NCT02309086</DOCNO>
	<brief_summary>Dendritic cell ( DC ) play central role activation T-cell responses show immunogenic preclinical vivo vitro assay . The aim study assess efficacy therapeutic vaccination pilot clinical trial Genotype 1 HCV patient use autologous DC transduce recombinant adenovirus encode NS3</brief_summary>
	<brief_title>Phase I-II Vaccination Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 Hepatitis C Encoding NS3 Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Chronic hepatitis C ( genotype 1b ) previously fail Interferon/Ribavirinbased treatment Liver cirrhosis HBVcoinfection Bilirubin &gt; 1.5 time ULN ALT &gt; 7 ULN Hepatocellular carcinoma Immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>